Ok Biotech Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 12, 2019 at 03:14 pm EST
Share
OK Biotech Co., Ltd. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 290.936 million compared to TWD 266.755 million a year ago. Operating income was TWD 25.110 million compared to TWD 43.517 million a year ago. Net income was TWD 38.263 million compared to TWD 49.190 million a year ago. Basic earnings per share was TWD 0.52 compared to TWD 0.65 a year ago. Diluted earnings per share was TWD 0.47 compared to TWD 0.63 a year ago. For the nine months, sales was TWD 866.141 million compared to TWD 817.797 million a year ago. Operating income was TWD 71.263 million compared to TWD 94.792 million a year ago. Net income was TWD 92.494 million compared to TWD 120.668 million a year ago. Basic earnings per share was TWD 1.27 compared to TWD 1.61 a year ago. Diluted earnings per share was TWD 1.11 compared to TWD 1.55 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
OK BIOTECH CO., LTD. 
